Below is a list of grant and award recipients. You may narrow the list down by using the filters below. The list can be sorted by year, last name, and institution. The institution listed reflects the sponsoring institution at the time of grant or award.
Past Recipients Year First Name Last Name Degree Institution Title Grant Amount ($)
2018 Jithma Abeykoon MD Mayo Clinic, Rochester Daratumumab-based therapies in patients with AL amyloidosis.
2018 Rajiv Agarwal MD Memorial Sloan Kettering Cancer Center Evaluating the Impact of Proactive Palliative Care in Patients Initiating Phase I Targeted or Immune-Based Cancer Therapeutics: A Randomized Controlled Trial 50,000.00
2018 Rajiv Agarwal MD Memorial Sloan Kettering Cancer Center Survival outcomes and end of life use of immunotherapy (IO) supplied free of charge for cancer patients.
2018 Ryan Anthony Francisco Agas MD University of Santo Tomas Hospital
2018 David Aggen MD, PhD Columbia University Targeting Myeloid-Derived Suppressor Cells in Renal Cell Cancer with Combination IL-1 Beta and PD-1 Blockade 50,000.00
2018 Ihnye Ahn MD National Cancer Institute Integration of drug-resistance mutations in risk prognostication and monitoring of treatment response in CLL 50,000.00
2018 Ayal Aizer MD Dana-Farber Cancer Institute Screening MRI of the brain in patients with high-risk, metastatic breast cancer: A prospective study 200,000.00
2018 Saud AlDubayan MD Dana-Farber Cancer Institute Dissecting inherited and acquired genetic mediators of testicular germ cell tumor (TGCT) initiation and progression 200,000.00
2018 Reham Abdelwahab Hassan Ali MD, PhD The University of Texas M.D. Anderson Cancer Center Geonomic and Immunologic Profiling in Asian versus Western Extrahepatic Cholangiocarcinoma Patients 50,000.00
2018 Eric Anderson MD Cedars-Sinai Medical Center Curative intent surgery and associated overall survival variation between elderly and younger patients in the National Cancer Database.
2018 Kathryn Arbour MD Memorial Sloan Kettering Cancer Center Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC.
2018 Kathryn Arbour MD Memorial Sloan Kettering Cancer Center Combination MEK and FGFR-1 Inhibition in KRAS-mutant NSCLC: A Phase I Dose Escalation Trial of Trametinib and Ponatinib 50,000.00
2018 Rita Assi MD The University of Texas M.D. Anderson Cancer Center Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML).
2018 Rereloluwa Nicodemus Babalola MBChB Obafemi Awolowo University Teaching Hospitals Complex, Nigeria
2018 Priscila Badia Alonso MD Cincinnati Children's Hospital Medical Center Sleep quality in hematopoietic stem cell transplant recipients and caregivers.
2018 Aanika Balaji Johns Hopkins University Immune-related adverse events requiring inpatient management: Spectrum of toxicity, treatment, and outcomes.
2018 Marina Baretti MD Johns Hopkins University A Phase 2 Clinical Trial of Entinostat in Combination with Nivolumab for Patients with Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma 50,000.00
2018 Romualdo Barroso-Sousa MD, PhD Dana-Farber Cancer Institute Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer.
2018 Mustafa Basree University of Pikeville Kentucky College of Osteopathic Medicine
2018 Francesca Battaglin MD University of South Carolina Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): data from TRIBE and FIRE-3 phase III trials.
2018 Cristiane Bergerot PhD, MS, BS City of Hope Differences in comprehension of somatic genomic profiling between younger and older adults with advanced genitourinary cancer.
2018 Cristiane Bergerot PhD, MS, BS Universidade Federal de São Paulo (UNIFESP) Differences in the way patient and partner experience the metastatic disease.
2018 Allison Betof Warner MD, PhD Memorial Sloan Kettering Cancer Center Exercise Regulation of Immune Activation and Response in Cancer: Implications for Immunotherapy 50,000.00
2018 Sushma Bhatnagar MD All India Institute of Medical Sciences, India Palliative Care:Promoting Access & International Cancer Experience in India Collaborative (PC-PAICE India Collaborative) 20,000.00
2018 Manali Bhave MD, BA Northwestern University A phase I/II study of the combination of temozolomide (TM) and pazopanib (PZ) in advanced pancreatic neuroendocrine tumors (PNETs) (NCT01465659).
2018 Bimal Bhindi MD, CM, MSc, FRCSC Mayo Clinic The probability of indolent versus aggressive histology based on renal tumor size: Implications for surveillance and treatment.
2018 Jimmy Awisan Billod MD Baguio General Hospital and Medical Center, Philippines
2018 Kari Bjornard MD, MPH St. Jude Children's Research Hospital Psychosexual functioning in sexually active female survivors of childhood cancer.
2018 Prajwal Boddu MD The University of Texas M.D. Anderson Cancer Center Validation of the ELN-2017 Risk Classification in Younger Adult Patients (pts) with AML.
2018 Joseph Bodor MD, PhD Fox Chase Cancer Center Pathogenic somatic mutation (SM) of mismatch repair (MMR) genes and associations with microsatellite instability (MSI), tumor mutational burden (TMB) and SM in other DNA repair pathways in 24,223 tumor genomic profiles.
2018 Dominick Bosse MD Dana-Farber Cancer Institute Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
2018 Dominick Bossé MD, MSc Dana-Farber Cancer Institute Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis.
2018 Elena Braicu MD, PhD Charité University Hospital, Germany Gene expression profiling using Nanostring technology to predict surgical outcome in advanced primary high grade serous ovarian cancer (HGSOC) patients (pts). Study of the Tumor Bank Ovarian Cancer (TOC).
2018 Edward Briercheck MD, PhD Dana-Farber Cancer Institute Novel Diagnostics for Lymphoma in Guatemala 50,000.00
2018 Samuel Brondfield MD University of California, San Francisco Implementation of a fellow-initiated financial toxicity screening tool in medical oncology clinics.
2018 Andrew Bruggeman MD University of California, San Diego Integration of Palliative Care into the Radiation Oncology Clinic 50,000.00
2018 Zachary Buchwald MD, PhD Emory University The role of the tumor draining lymph node in induction of the abscopal effect 50,000.00
2018 Yanshuo Cao MD Princess Margaret Cancer Centre, Canada Lenalidomide (LEN) pharmacokinetics (PKs) in multiple myeloma (MM) patients (pts) with various renal functions.
2018 Luisa Carbognin MD University of Verona Next-Generation Targeted Sequencing (NGTS) investigating CDK4 as a prognostic driver in pure Invasive Lobular Breast Carcinoma (ILC): preliminary results in early-stage patients (pts) stratified according to a validated clinico-pathological model.
2018 Tina Cascone MD, PhD The University of Texas M.D. Anderson Cancer Center Neoadjuvant immune checkpoint blockade to enhance immune responses and improve clinical efficacy for the treatment of resectable NSCLC. 200,000.00
2018 Alessia Castellino MD Mayo Clinic, Rochester Title: Long term follow-up (FU) of lenalidomide plus R-CHOP therapy in patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): combined analysis from two phase 2 trials.
2018 Elizabeth Cathcart-Rake MD Mayo Clinic Immunotherapy-related toxicities: More common than originally reported?
2018 Fernando Caumont MD Virginia Mason Medical Center Primary Testicular Lymphoma: Treatment Patterns and Survival of 1740 Men From the National Cancer Database.
2018 Pauline Anne Peronilla Cauton MD St. Luke's Medical Center, Philippines
2018 Jad Chahoud MD The University of Texas M.D. Anderson Cancer Center Glypican 3 (GPC3) expression in a lethal subgroup of refractory cisplatin-resistant testicular germ cell tumor (TGCT).
2018 Jad Chahoud MD The University of Texas M.D. Anderson Cancer Center Identification of viral and immune biomarkers for metastasis and poor survival in penile squamous cell carcinoma 50,000.00
2018 Anita Chanana Other Stanford University
2018 Mariana Chavez Mac Gregor MD, MSc The University of Texas M.D. Anderson Cancer Center Understanding barriers and decreasing the time to chemotherapy in a vulnerable population: Pilot study of a targeted intervention 450,000.00
2018 Huizi Chen MD, PhD The Ohio State University Research Autopsy for Characterization of Recurrent Small Cell Lung Cancer 50,000.00
2018 Fumiko Chino MD, BA Duke University Trends and disparities in place of death for cancer patients in the United States, 1999-2015.